Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8723559 | Médecine des Maladies Métaboliques | 2016 | 9 Pages |
Abstract
Randomized controlled trials (RCT) are considered as the gold standard in the hierarchy of research designs for evaluating the efficacy and safety of a treatment intervention. They have long been regarded as the sole basis of the evidence-based medicine (EBM). Nevertheless, their conclusions can have limited applicability to patients in clinical settings. Observational studies using large health care databases can complement findings from RCT by assessing treatment effectiveness in patients encountered in day-to-day clinical practice. Results from these designs can expand upon outcomes of RCT because of the use of larger and more diverse patient populations with common comorbidities and longer follow-up periods. Furthermore, well-designed observational studies can identify clinically important differences among therapeutic options and provide data on long-term drug effectiveness and safety.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
S. Halimi, S. Dejager,